Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Keith Michael Gottesdiener Insider Profile
4 Followers
Keith Michael Gottesdiener, Director at Intercept Pharma, holds 4.36M shares in Prime Medicine, Inc. (Ticker: PRME), holds 32.83K shares in Intercept Pharma (Ticker: ICPT), holds 558.25K shares in Rhythm Pharmaceuticals (Ticker: RYTM).
Keith Michael Gottesdiener Intercept Pharma (ICPT)Director
Intercept Pharma (ICPT)
Director
Ranked #14,147 out of 98,909 Corporate Insiders
Profitable Transactions
3 out of 4 Profitable Transactions
Average Return
+35.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Keith Michael Gottesdiener holds in companies
Most Profitable Insider Trade
Stock:
Intercept Pharma
(ICPT)
(ICPT)
Rating:Informative Buy
Date:Apr 09, 2018 - Apr 09, 2019
Return:+70.90%
The most profitable trade made by Keith Michael Gottesdiener
Keith Michael Gottesdiener's Trading History
Intercept Pharma
May 25, 2023
―
Uninformative Buy
―
$623.77K
Rhythm Pharmaceuticals
Mar 11, 2020
CEO & President, Director
Uninformative Buy
20.93K
$22.44M
Prime Medicine, Inc.
Nov 14, 2023
President & CEO, Director
Uninformative Sell
―
$28.00M
List of latest transactions for each holding click on a transaction to see Keith Michael Gottesdiener's performance on stock
You May Also Like
Keith Michael Gottesdiener insider profile FAQ
What is the percentage of profitable transactions made by Keith Michael Gottesdiener?
The percentage of profitable transactions made by Keith Michael Gottesdiener is 75%.
What is the average return per transaction made by Keith Michael Gottesdiener?
The average return per transaction made by Keith Michael Gottesdiener is 35.10%.
What stocks does Keith Michael Gottesdiener hold?
Keith Michael Gottesdiener holds: ICPT, RYTM, PRME stocks.
What was Keith Michael Gottesdiener’s latest transaction?
Keith Michael Gottesdiener latest transaction was an Uninformative Sell of ―.
What was Keith Michael Gottesdiener's most profitable transaction?
Keith Michael Gottesdiener’s most profitable transaction was an Informative Buy of ICPT stock on April 9, 2018. The return on the trade was 70.90%.
What is Keith Michael Gottesdiener's role in Intercept Pharma?
Keith Michael Gottesdiener's role in Intercept Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.